Biochemical and structural characterization of the human TL1A ectodomain

Biochemistry

Volumn 48, Issue 32, 2009, Pages 7636-7645

  Zhan, Chenyang ^a   Yan, Qingrong ^a   Patskovsky, Yury ^a   Li, Zhenhong ^a   Toro, Rafael ^a   Meyer, Amanda ^a   Cheng, Huiyong ^a   Brenowitz, Michael ^a   Nathenson, Stanley G ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL STUDIES; AUTOIMMUNE DISEASE; BINDING INTERFACE; BIOCHEMICAL CHARACTERIZATION; CELL-BASED; DISULFIDE BONDING; ECTODOMAIN; EXTRACELLULAR DOMAINS; INFLAMMATORY BOWEL DISEASE; RATIONAL MANIPULATION; RHEUMATOID ARTHRITIS; SOLUTION PROPERTY; STRUCTURAL CHARACTERIZATION; STRUCTURAL INFORMATION;

CELL MEMBRANES;

CRYSTAL STRUCTURE;

DECOY RECEPTOR 3; MEMBRANE RECEPTOR; MUTANT PROTEIN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DISULFIDE BOND; HUMAN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DISULFIDES; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; SEQUENCE ALIGNMENT; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

ANIMALIA;

EID: 68849112042     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900031w     Document Type: Article

References (40)

1. Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S. F., Zhou, J. X., Cho, Y. H., Ullrich, S., Kanakaraj, P., Carrell, J., Boyd, E., Olsen, H. S., Hu, G., Pukac, L., Liu, D., Ni, J., Kim, S., Gentz, R., Feng, P., Moore, P. A., Ruben, S. M., and Wei, P. (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492.
2. Chew, L. J., Pan, H., Yu, J., Tian, S., Huang, W. Q., Zhang, J. Y., Pang, S., and Li, L. Y. (2002) A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J. 16, 742-744.
3. Yang, C. R., Hsieh, S. L., Teng, C. M., Ho, F. M., Su, W. L., and Lin, W. W. (2004) Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Res. 64, 1122-1129.
4. Bamias, G., Mishina, M., Nyce, M., Ross, W. G., Kollias, G., Rivera-Nieves, J., Pizarro, T. T., and Cominelli, F. (2006) Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. U.S.A. 103, 8441-8446.
5. Pappu, B. P., Borodovsky, A., Zheng, T. S., Yang, X., Wu, P., Dong, X., Weng, S., Browning, B., Scott, M. L., Ma, L., Su, L., Tian, Q., Schneider, P., Flavell, R. A., Dong, C., and Burkly, L. C. (2008) TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205, 1049-1062.
6. Meylan, F., Davidson, T. S., Kahle, E., Kinder, M., Acharya, K., Jankovic, D., Bundoc, V., Hodges, M., Shevach, E. M., Keane-Myers, A., Wang, E. C., and Siegel, R. M. (2008) The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79-89.
7. Bai, C., Connolly, B., Metzker, M. L., Hilliard, C. A., Liu, X., Sandig, V., Soderman, A., Galloway, S. M., Liu, Q., Austin, C. P., and Caskey, C. T. (2000) Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. U.S.A. 97, 1230-1235.
8. Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., Godowski, P. J., Wood, W. I., Gurney, A. L., Hillan, K. J., Cohen, R. L., Goddard, A. D., Botstein, D., and Ashkenazi, A. (1998) Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699-703.
9. Yu, K. Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R., and Kwon, B. S. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274, 13733-13736.
10. Hsu, T. L., Wu, Y. Y., Chang, Y. C., Yang, C. Y., Lai, M. Z., Su, W. B., and Hsieh, S. L. (2005) Attenuation of Th1 response in decoy receptor 3 transgenic mice. J. Immunol. 175, 5135-5145.
11. Wu, S. F., Liu, T. M., Lin, Y. C., Sytwu, H. K., Juan, H. F., Chen, S. T., Shen, K. L., Hsi, S. C., and Hsieh, S. L. (2004) Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication. J. Leukocyte Biol. 75, 293-306.
12. Hsu, T. L., Chang, Y. C., Chen, S. J., Liu, Y. J., Chiu, A. W., Chio, C. C., Chen, L., and Hsieh, S. L. (2002) Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J. Immunol. 168, 4846-4853.
13. Takahama, Y., Yamada, Y., Emoto, K., Fujimoto, H., Takayama, T., Ueno, M., Uchida, H., Hirao, S., Mizuno, T., and Nakajima, Y. (2002) The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer 5, 61-68.
14. Sung, H. H., Juang, J. H., Lin, Y. C., Kuo, C. H., Hung, J. T., Chen, A., Chang, D. M., Chang, S. Y., Hsieh, S. L., and Sytwu, H. K. (2004) Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 199, 1143-1151.
15. Compaan, D. M., and Hymowitz, S. G. (2006) The crystal structure of the costimulatory OX40-OX40L complex. Structure 14, 1321-1330.
16. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H., and Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431-445.
17. Mongkolsapaya, J., Grimes, J. M., Chen, N., Xu, X. N., Stuart, D. I., Jones, E. Y., and Screaton, G. R. (1999) Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat. Struct. Biol. 6, 1048-1053.
18. Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., and de Vos, A. M. (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 4, 563-571.
19. Locksley, R. M., Killeen, N., and Lenardo, M. J. (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501.
20. Kang, Y. J., Kim, W. J., Bae, H. U., Kim, D. I., Park, Y. B., Park, J. E., Kwon, B. S., and Lee, W. H. (2005) Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 29, 229-235.
21. Borysenko, C. W., Furey, W. F., and Blair, H. C. (2005) Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis. Biochem. Biophys. Res. Commun. 328, 794-799.
22. Yamazaki, K., McGovern, D., Ragoussis, J., Paolucci, M., Butler, H., Jewell, D., Cardon, L., Takazoe, M., Tanaka, T., Ichimori, T., Saito, S., Sekine, A., Iida, A., Takahashi, A., Tsunoda, T., Lathrop, M., and Nakamura, Y. (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14, 3499-3506.
23. Young, H. A., and Tovey, M. G. (2006) TL1A: a mediator of gut inflammation. Proc. Natl. Acad. Sci. U.S.A. 103, 8303-8304.
24. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
25. Storoni, L. C., McCoy, A. J., and Read, R. J. (2004) Likelihood-enhanced fast rotation functions. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60, 432-438.
26. Evrard, G. X., Langer, G. G., Perrakis, A., and Lamzin, V. S. (2007) Assessment of automatic ligand building in ARP/wARP. Acta Crystallogr., Sect. D: Biol. Crystallogr. 63, 108-117.
27. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr., Sect. D: Biol. Crystallogr. 53, 240-255.
28. Jin, T., Guo, F., Kim, S., Howard, A., and Zhang, Y. Z. (2007) X-ray crystal structure of TNF ligand family member TL1A at 2.1 Å. Biochem. Biophys. Res. Commun. 364, 1-6.
29. Philo, J. S. (2000) A method for directly fitting the time derivative of sedimentation velocity data and an alternative algorithm for calculating sedimentation coefficient distribution functions. Anal. Biochem. 279, 151-163.
30. Laue, T. M., Shah, B. D., Ridgeway, T. M., Pelletier, S. L. (1991) Analytical Ultracentrifugation in Biochemistry and Polymer Science , Royal Society for Chemistry, Cambridge, U.K.
31. Holm, L., and Park, J. (2000) DaliLite workbench for protein structure comparison. Bioinformatics 16, 566-567.
32. Eck, M. J., and Sprang, S. R. (1989) The structure of tumor necrosis factor-alpha at 2.6 Å resolution. Implications for receptor binding. J. Biol. Chem. 264, 17595-17605.
33. Bodmer, J. L., Meier, P., Tschopp, J., and Schneider, P. (2000) Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL. J. Biol. Chem. 275, 20632-20637.
34. Kim, S., and Zhang, L. (2005) Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine. J. Immunol. Methods 298, 1-8.
35. Bodmer, J. L., Schneider, P., and Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26.
36. Yamagishi, J., Kawashima, H., Matsuo, N., Ohue, M., Yamayoshi, M., Fukui, T., Kotani, H., Furuta, R., Nakano, K., and Yamada, M. (1990) Mutational analysis of structure-activity relationships in human tumor necrosis factor-alpha. Protein Eng. 3, 713-719.
37. Schneider, P., Bodmer, J. L., Holler, N., Mattmann, C., Scuderi, P., Terskikh, A., Peitsch, M. C., and Tschopp, J. (1997) Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol. Chem. 272, 18827-18833.
38. Goh, C. R., Loh, C. S., and Porter, A. G. (1991) Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin). Protein Eng. 4, 785-791.
39. Hymowitz, S. G., O'Connell, M. P., Ultsch, M. H., Hurst, A., Totpal, K., Ashkenazi, A., de Vos, A. M., and Kelley, R. F. (2000) A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39, 633-640.
40. Rooney, I. A., Butrovich, K. D., Glass, A. A., Borboroglu, S., Benedict, C. A., Whitbeck, J. C., Cohen, G. H., Eisenberg, R. J., and Ware, C. F. (2000) The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem. 275, 14307-14315.